A lack of neo-antigenic mutations in combination with defects in either MHC expression or other components of the antigen presenting gear of the tumor cells might explain the intrinsic resistance to immune checkpoint inhibitor therapy. The gene discussed is HLA-C; the disease is neoplasm.